Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Wafa Bashir"'
Publikováno v:
Sultan Qaboos University Medical Journal, Vol 12, Iss 4, Pp 498-502 (2012)
An extremely premature male neonate presented with an unusual multisystem dysfunction within the first 24 to 48 hours of life. The unfolding of clinical events and investigations revealed a transient myeloproliferative disorder (TMD). TMD was the mai
Externí odkaz:
https://doaj.org/article/5aa70e27a79549a592ca52c514cc0bef
Autor:
Abeer Abdelrazig Osman, Hadia Abass Eltaib, Ghanem Mohammed Mahjaf, Tibyan Abd Almajed Altaher, Wafa Bashir Haj Ahmed, Mosab Nouraldein Mohammed Hamad
Publikováno v:
SAR Journal of Pathology and Microbiology. 4:7-10
Background: Operating room contamination is recognized as one of the most common life-threatening microbial contaminations in hospital environments, especially operating rooms and other specialty units, and is an ever- increasing cause of nosocomial
Autor:
Wafa Bashir, Faiza Taha
Background: Preconception care is an essential component of reproductive health which does not have a footprint in our health care system in Sudan. Every woman of reproductive age who is capable of becoming pregnant is a candidate for preconception c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0007a1604541f5fcca8b2bac546cd9c5
Autor:
Ismail Beshlawi, Shoaib Al Zadjali, Wafa Bashir, Yasser Wali, Mohamed Elshinawy, Abdulhakim Al-Rawas
Publikováno v:
Pediatric Blood & Cancer. 61:528-531
Background Thiamine responsive megaloblastic anemia (TRMA) is characterized by a triad of megaloblastic anemia, non-type 1 diabetes mellitus and sensorineural deafness. Other clinical findings have been described in few cases. The SLC19A2 gene on chr
Autor:
Mathew Zachariah, Wafa Bashir, Surekha Tony, Yasser Wali, Ismail El-Beshlawi, Abdulhakim Al-Rawas, Mohamed Elshinawy
Publikováno v:
Pediatric Hematology and Oncology. 31:442-447
The role of erythropoiesis-stimulating agents (ESAs) in the management of chemotherapy-induced anemia (CIA) is becoming increasingly recognized in the field of medical oncology, with paucity of data in pediatrics. We evaluated the efficacy and tolera
Autor:
Yasser Wali, Zakiya Al Lamki, Wafa Bashir, Mathew Zacharia, Rajeev Jain, Anil Pathare, Ranjan R. William, Salam Alkindi, Arunodaya R. Gujjar, Abdullah Al-Asmi
Publikováno v:
Journal of Pediatric Hematology/Oncology. 35:18-23
Changes on Transcranial Doppler (TCD) ultrasonography have been proposed as significant predictors of cerebrovascular complications in sickle cell disease (SCD). However, consensus with regards to the TCD criteria to recognize abnormalities in cerebr
Autor:
Coro Paisán-Ruiz, Volkmar Gieselmann, Matthias Eckhardt, Sandy Raeburn, Aisha Alkhayat Alshehhi, Katherine J. Dick, Naomi A. Sibtain, Michael A. Patton, Christos Proukakis, Wafa Bashir, Andrew H. Crosby, Henry Houlden, Roshan Koul, Helena Maier, Reza Sharifi
Publikováno v:
Human Mutation. 31:E1251-E1260
Hereditary spastic paraplegia (HSP) describes a heterogeneous group of inherited neurodegenerative disorders in which the cardinal pathological feature is upper motor neurone degeneration leading to progressive spasticity and weakness of the lower li
Autor:
Yasser Wali, Ashfaq Ahmed Khan, Achandira M. Udayakumar, Anil Pathare, Heba Soliman, John Alexander Raeburn, Wafa Bashir, Zakia Al-Lamki, Mathew Zacharia
Publikováno v:
Archives of Medical Research. 38:305-312
Background Chromosomal abnormalities have important diagnostic and prognostic significance in acute lymphoblastic leukemia (ALL). The purpose of this study was to define and classify the frequency and type of chromosomal abnormalities among newly dia
Publikováno v:
International Journal of Hematology. 98:240-242
We report the presence of two different dglobin gene mutations causing d?-thalassemia in association with homozygous (-a3.7/-a3.7) genotype for the first time in an Omani child with a low hemoglobin A2 (HbA2) of 0.8 %. Direct nucleotide sequencing re
Publikováno v:
Pediatric hematology and oncology. 30(2)
Iron overload is mainly responsible for the morbidity and mortality in patients with beta thalassemia major (TM). Our aim was to compare treatment outcomes with oral iron chelators, deferiprone (DFP), and deferasirox (DFX) in the first two decades on